Endoceutics’s Intrarosa Gets Approval from US FDA
The US FDA approved Intrarosa for the treatment of dyspareunia experienced by women who attained menopause. Dyspareunia is moderate to
Read moreus fda
Eli Lilly’s Lartruvo Gets FDA Accelerated Approval to Treat Soft Tissue Sarcoma
U.S. regulatory authority Food and Drug Administration on 19th October 2016, granted accelerated approval to Eli Lilly’s Lartruvo, a drug
Read moreUS FDA Discloses Guidance on SaMD for Consultation
US regulatory authority Food and Drug Administration (FDA) on 13th October 2016, opened a public a consultation on a harmonized
Read moreExondys 51: First Drug to Treat DMD Gets Approval from US FDA
The US regulatory authority on 18th Sep approved Exondys 51 (eteplirsen), Sarepta Therapeutics’ initial drug to treat individuals with Duchenne
Read moreShire’s Xiidra Gets US FDA Approval
US Food and Drug Administration approved Xiidra, which is lifitegrast ophthalmic solution 5 %,used to treat dry eye disease. Xiidra
Read moreFirst Buprenorphine Implant for Opioid Dependence Gets green Signal from US FDA
The U.S. Food and Drug Administration on 27th May accepted Probuphine, the first buprenorphine implant for the maintenance therapy of
Read moreUS FDA Proposes Ban on Powdered Gloves
US Food and Drug Administration (FDA) has chosen to ban most powdered gloves due to the fact that they cause
Read moreBriviact Received Green Light from US FDA to Treat Partial Onset Seizures
The US FDA on 18th Feb 2016 accepted Briviact (brivaracetam) as an add-on therapy to other drugs to treat partial
Read moreAstraZeneca’s Zurampic Received Green Signal from US FDA
The U.S. FDA on 23rd Dec 2015 accepted Zurampic (lesinurad) to treat higher levels of uric acid in the blood
Read moreTakeda’s Ninlaro Gets Approval from US FDA for Multiple Myeloma
On 20th Nov 2015 the U.S. FDA provided acceptance for (ixazomib) in combo with two other therapies to treat patients
Read more